| |
Mean ± SD
|
Range
|
Median
|
|---|
|
Age (years)
|
58 ± 8
|
43–73
|
58
|
|
PUA (°)
|
57.5 ± 9.62
|
45–81.4
|
54.25
|
|
TPV (ml)
|
46.8 ± 18.13
|
27–97.47
|
42
|
|
TZV (ml)
|
34.1 ± 10.3
|
21–62.97
|
32
|
|
TZI
|
0.75 ± 0.12
|
0.45–0.9
|
0.79
|
|
AFMS distance (mm)
|
30.8 ± 7
|
19.7–49.5
|
30.6
|
|
IPP (mm)
|
3.3 ± 6.47
|
0–29.3
|
0
|
|
Qmax (ml/s)
|
18 ± 8.24
|
3.7–32
|
15.25
|
|
IPSS score
|
12.7 ± 7.76
|
5–30
|
9.5
|
|
PVR (ml)
|
69.8 ± 63
|
5–240
|
53
|
|
Total PSA (ng/ml)
|
3.1 ± 2.74
|
0.34–8.94
|
2.1
|
- PUA prostatic urethral angle; TPV total prostate volume; TZV transition zone volume; TZI transition zone index; IPP intravesical prostatic protrusion; AFMS anterior fibromuscular stroma; Qmax maximum flow rate; IPSS International Prostate Symptom Score; PVR postvoid residual urine; PSA prostatic specific antigen
